Literature DB >> 2587047

Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy.

J E Grunwald1, A J Brucker, B L Petrig, C E Riva.   

Abstract

Bidirectional laser Doppler velocimetry and monochromatic fundus photography were used to investigate retinal hemodynamics before and after panretinal photocoagulation (PRP) in 25 eyes of 23 diabetic patients with proliferative retinopathy. After PRP, there was a significant decrease in retinal volumetric blood flow rate and an increase in the retinal vascular regulatory response to hyperoxia (R). A significant association was found between the presence or absence of regression of neovascularization and the increase or decrease in R after PRP. Eyes that showed regression of neovascularization had significantly larger average R after PRP than eyes that did not show regression. Lack of improvement in R after PRP may be related to the presence of remaining ischemia or hypoxia in eyes that continue to show proliferation after PRP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2587047     DOI: 10.1016/s0161-6420(89)32697-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

1.  Macular circulation in patients with diabetes mellitus with and without arterial hypertension.

Authors:  O Arend; M Rüffer; A Remky
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Reliability of vessel diameter measurements with a retinal oximeter.

Authors:  Renata Blondal; Margret Kara Sturludottir; Sveinn Hakon Hardarson; Gisli Hreinn Halldorsson; Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-16       Impact factor: 3.117

3.  Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.

Authors:  Jonathan F Russell; Hasenin Al-Khersan; Yingying Shi; Nathan L Scott; John W Hinkle; Kenneth C Fan; Cancan Lyu; William J Feuer; Giovanni Gregori; Philip J Rosenfeld
Journal:  Am J Ophthalmol       Date:  2020-03-13       Impact factor: 5.258

4.  Regional retinal blood flow reduction following half fundus photocoagulation treatment.

Authors:  N Fujio; G T Feke; D G Goger; J W McMeel
Journal:  Br J Ophthalmol       Date:  1994-05       Impact factor: 4.638

5.  Assessing total retinal blood flow in diabetic retinopathy using multiplane en face Doppler optical coherence tomography.

Authors:  Alex D Pechauer; Thomas S Hwang; Ahmed M Hagag; Liang Liu; Ou Tan; Xinbo Zhang; Maria Parker; David Huang; David J Wilson; Yali Jia
Journal:  Br J Ophthalmol       Date:  2017-05-11       Impact factor: 4.638

Review 6.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

7.  Improved Macular Capillary Flow on Optical Coherence Tomography Angiography After Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.

Authors:  Amani A Fawzi; Alaa E Fayed; Robert A Linsenmeier; Jing Gao; Fei Yu
Journal:  Am J Ophthalmol       Date:  2019-05-10       Impact factor: 5.258

8.  Changes in choroidal vascular parameters following pan-retinal photocoagulation using swept-source optical coherence tomography.

Authors:  Jee Taek Kim; Nari Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-03       Impact factor: 3.117

9.  Vascular Density of Deep, Intermediate and Superficial Vascular Plexuses Are Differentially Affected by Diabetic Retinopathy Severity.

Authors:  Mohamed Ashraf; Konstantina Sampani; Allen Clermont; Omar Abu-Qamar; Jae Rhee; Paolo S Silva; Lloyd Paul Aiello; Jennifer K Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

10.  Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging.

Authors:  A M Avunduk; H Dinç; Z Kapicioğlu; S Uğurlu; V Dayanir; E Korkmaz
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.